Literature DB >> 7814501

Pneumococcal resistance to antimicrobial agents in the province of Québec, Canada.

L P Jetté1, L Ringuette, A Dascal, J R Lapointe, P Turgeon.   

Abstract

The serogroup/serotypes (SGTs) and antimicrobial susceptibilities to 10 antimicrobial agents of 110 clinical strains of Streptococcus pneumoniae were determined. Strains intermediately resistant or highly resistant to penicillin G (80 of 110) belonged predominantly to SGTs 23 (45.0%), 19 (13.7%), 6 (10.0%), 9 (6.2%), and 14 (3.7%). The MICs of all cephalosporins, tetracycline, trimethoprim-sulfamethoxazole, and chloramphenicol increased along with the MICs of penicillin G. However, erythromycin resistance and clindamycin resistance were observed more frequently among the intermediately penicillin-resistant strains. Multiple resistance was observed for 32 strains, of which 25 were highly resistant to penicillin G and belong to SGT 23F. All strains were susceptible to vancomycin.

Entities:  

Mesh：

Year:  1994        PMID： 7814501      PMCID： PMC264105          DOI： 10.1128/jcm.32.10.2572-2575.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989.

Authors:  A Fenoll; C Martín Bourgon; R Muñóz; D Vicioso; J Casal
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

2.  Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group.

Authors:  J S Spika; R R Facklam; B D Plikaytis; M J Oxtoby
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

Review 3.  Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment.

Authors:  D M Musher
Journal:  Clin Infect Dis       Date:  1992-04       Impact factor: 9.079

4.  Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986.

Authors:  K P Klugman; H J Koornhof
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

5.  Meningitis in a Canadian infant due to pneumococcus resistant to penicillin and chloramphenicol.

Authors:  J R Lapointe; J H Joncas
Journal:  J Pediatr       Date:  1983-10       Impact factor: 4.406

Review 6.  Pneumococcal resistance to antibiotics.

Authors:  K P Klugman
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

7.  Emergence of drug-resistant pneumococcal infections in the United States.

Authors:  R F Breiman; J C Butler; F C Tenover; J A Elliott; R R Facklam
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

Review 8.  A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe.

Authors:  F Baquero; J Martínez-Beltrán; E Loza
Journal:  J Antimicrob Chemother       Date:  1991-12       Impact factor: 5.790

9.  Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae.

Authors:  R Muñoz; T J Coffey; M Daniels; C G Dowson; G Laible; J Casal; R Hakenbeck; M Jacobs; J M Musser; B G Spratt
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

10.  Streptococcus pneumoniae resistant to penicillin and chloramphenicol.

Authors:  P C Appelbaum; A Bhamjee; J N Scragg; A F Hallett; A J Bowen; R C Cooper
Journal:  Lancet       Date:  1977-11-12       Impact factor: 79.321
View more
  9 in total

Review 1.  Preventing pneumococcal disease.

Authors:  R Thomas
Journal:  Can Fam Physician       Date:  1998-10       Impact factor: 3.275

2.  Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae.

Authors:  F C Tenover; C N Baker; J M Swenson
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics.

Authors:  L P Jetté; G Delage; L Ringuette; R Allard; P De Wals ; F Lamothe; V Loo
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995.

Authors:  M Lovgren; J S Spika; J A Talbot
Journal:  CMAJ       Date:  1998-02-10       Impact factor: 8.262

5.  Distribution of capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae isolated from aborigines in central Australia.

Authors:  M Gratten; P Torzillo; F Morey; J Dixon; J Erlich; J Hagger; J Henrichsen
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

6.  Meningitis in a Canadian adult due to high level penicillin-resistant, cefotaxime-intermediate Streptococcus pneumoniae.

Authors:  C Tremblay; A M Bourgault; P St-Antoine
Journal:  Can J Infect Dis       Date:  1996-05

Review 7.  Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.

Authors:  R N Brogden; C M Spencer
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

8.  Reporting Emerging Resistance of Streptococcus pneumoniae from India.

Authors:  Kiran Chawla; Bimala Gurung; Chiranjay Mukhopadhyay; Indira Bairy
Journal:  J Glob Infect Dis       Date:  2010-01

9.  Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan.

Authors:  C C Chiou; Y C Liu; T S Huang; W K Hwang; J H Wang; H H Lin; M Y Yen; K S Hsieh
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.